Literature DB >> 30968701

Advanced glycation end products as biomarkers in systemic diseases: premises and perspectives of salivary advanced glycation end products.

Anida M Băbţan1, Aranka Ilea1, Bianca A Boşca2, Maria Crişan2, Nausica B Petrescu1, Massimo Collino3, Rosa M Sainz4, Jared Q Gerlach5, Radu S Câmpian1.   

Abstract

Advanced glycation end products (AGEs) are glycated proteins associated with high dry temperature food processing, coloring and flavor modification of food products. Previous studies on diet-related disease support the role of the glycation products as biomarkers in local and general proinflammatory response. Exogenous and endogenous AGEs are involved in chronic low-level inflammation, which underlies the onset of metabolic syndrome influenced by food intake, there by demonstrating their implication in diet-related pathologies. Although studies have revealed a strong association between the accumulation of AGEs and the occurrence/worsening of metabolic diseases, their routine use for the diagnosis or monitoring of local and general disease has not yet been reported.

Entities:  

Keywords:  AGEs; AGEs diagnosis and downregulation; advanced glycation end products; biomarkers; biosensor; chronic low-level inflammation; diet-related disease; metabolic syndrome; metainflammation; saliva

Mesh:

Substances:

Year:  2019        PMID: 30968701     DOI: 10.2217/bmm-2018-0448

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  5 in total

Review 1.  AGE/Non-AGE Glycation: An Important Event in Rheumatoid Arthritis Pathophysiology.

Authors:  Prachi Agnihotri; Sagarika Biswas
Journal:  Inflammation       Date:  2021-11-17       Impact factor: 4.092

Review 2.  Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.

Authors:  Aleksandra Twarda-Clapa; Aleksandra Olczak; Aneta M Białkowska; Maria Koziołkiewicz
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

Review 3.  The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.

Authors:  Narasimha M Beeraka; Venugopal R Bovilla; Shalini H Doreswamy; Sujatha Puttalingaiah; Asha Srinivasan; SubbaRao V Madhunapantula
Journal:  Cancers (Basel)       Date:  2021-01-14       Impact factor: 6.639

4.  Using the Key Characteristics of Carcinogens to Develop Research on Chemical Mixtures and Cancer.

Authors:  Cynthia V Rider; Cliona M McHale; Thomas F Webster; Leroy Lowe; William H Goodson; Michele A La Merrill; Glenn Rice; Lauren Zeise; Luoping Zhang; Martyn T Smith
Journal:  Environ Health Perspect       Date:  2021-03-30       Impact factor: 9.031

5.  The relationship between advanced glycation end products and gestational diabetes: A systematic review and meta-analysis.

Authors:  Mekonnen Sisay; Dumessa Edessa; Tilahun Ali; Abraham Nigussie Mekuria; Alemu Gebrie
Journal:  PLoS One       Date:  2020-10-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.